HtrA3 inhibitors are a class of chemical compounds that specifically target and inhibit the function of **HtrA3**, a member of the high-temperature requirement A (HtrA) family of serine proteases. HtrA3 is involved in a range of cellular processes, particularly those related to protein quality control, apoptosis, and cellular stress responses. As a serine protease, HtrA3 plays a crucial role in cleaving misfolded or damaged proteins to prevent the accumulation of toxic aggregates. By inhibiting HtrA3, these compounds interfere with its proteolytic activity, leading to disruptions in the degradation of damaged proteins. This provides researchers with an important tool to study the mechanisms of proteostasis, which involves the regulation of protein synthesis, folding, and degradation within cells.
The inhibition of HtrA3 allows scientists to explore how cells respond to an imbalance in protein homeostasis, particularly under conditions of stress, such as oxidative damage or heat shock. HtrA3 inhibitors are used to investigate the broader impact of protease activity on cellular pathways, including the regulation of apoptosis and the unfolded protein response (UPR). By blocking HtrA3 activity, researchers can observe how the buildup of misfolded proteins affects cellular processes such as signal transduction, cell survival, and protein trafficking. Additionally, studying HtrA3 inhibitors provides valuable insights into the specific role of serine proteases in maintaining protein quality control and how disruptions in these processes contribute to cellular dysfunction. These inhibitors are essential tools for understanding the complex networks involved in proteolysis and the maintenance of cellular homeostasis in both normal and stressed environments.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could hypothetically lead to the demethylation of the HtrA3 gene promoter, subsequently reducing its transcription and decreasing the protein levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound may promote hyperacetylation of histone proteins near the HtrA3 gene locus, potentially repressing transcriptional activity and decreasing HtrA3 synthesis. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A may bind selectively to the HtrA3 promoter region, obstructing the binding of transcription factors necessary for its expression, resulting in decreased mRNA synthesis for HtrA3. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA, Actinomycin D could specifically block the transcriptional elongation of the HtrA3 gene, leading to a reduction in HtrA3 mRNA levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may inhibit mTOR activity, which is responsible for the translation of many proteins, potentially leading to decreased levels of HtrA3 protein due to reduced translation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 could inhibit the activity of PI3K, leading to reduced AKT phosphorylation and subsequent downstream transcriptional repression, which would decrease HtrA3 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
By selectively inhibiting MEK1/2, U0126 could reduce ERK pathway signaling, potentially leading to a decrease in transcription factors that drive HtrA3 gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 could selectively inhibit p38 MAPK, resulting in downregulation of stress-responsive transcription factors that are hypothesized to be upstream activators of HtrA3 expression. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
As a metabolite of estradiol, 2-Methoxyestradiol may downregulate transcriptional activators or signal transduction pathways involved in the expression of the HtrA3 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could exert its effect by downregulating specific transcription factors or coactivators required for HtrA3 gene transcription, leading to decreased protein expression. | ||||||